Jeff Yass’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
Other funds holding PMCB
Jeff Yass's PMCB Position: Q3 2026 in Review
Jeff Yass reduced its PharmaCyte Biotech (PMCB) stake by 33% in Q3 2026, selling an estimated $8.14K and leaving 1,582 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #13205.
Jeff Yass first reported a position in PMCB in Q1 2022 and has held it in 13 quarters since. The position peaked at $311K in Q1 2023. 20 funds tracked by Wall St. Rank hold PMCB as of Q3 2026.
- Jeff Yass held 1,582 shares of PharmaCyte Biotech worth $12.3K as of Q3 2026.
- Jeff Yass sold 779 PharmaCyte Biotech shares in Q3 2026, an estimated $8.14K.
- PharmaCyte Biotech made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #13205 holding.
- Jeff Yass first reported a position in PharmaCyte Biotech in Q1 2022 and has held it in 13 quarters since.
- Jeff Yass's PharmaCyte Biotech position peaked at $311K in Q1 2023.
- 20 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.